Skip to content
10-Q

Quarterly Report

LogicBio Therapeutics, Inc.

0001564590-22-037503

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 8, 2022 32.96M sh
Shares Diluted Q3 2022 · Sep 30, 2022 32.96M sh
Shares Diluted Q3 2022 · Sep 30, 2022 32.96M sh
Shares Diluted Q3 2022 · Sep 30, 2021 32.44M sh
Shares Diluted Q3 2022 · Sep 30, 2021 32.18M sh
Capex Q3 2022 · Sep 30, 2022 $100K
Capex Q3 2022 · Sep 30, 2021 $734K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$20.1M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$13.83M
Long Term Debt Q3 2022 · Sep 30, 2022 $2.63M
Long Term Debt Q3 2022 · Dec 31, 2021 $5.01M
Short Term Debt Q3 2022 · Sep 30, 2022 $3.31M
Short Term Debt Q3 2022 · Dec 31, 2021 $3.3M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $30.78M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $53.48M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $59.58M
Stockholders Equity Q3 2022 · Sep 30, 2022 $15.74M
Stockholders Equity Q3 2022 · Dec 31, 2021 $30.73M
Current Liabilities Q3 2022 · Sep 30, 2022 $16.43M
Current Liabilities Q3 2022 · Dec 31, 2021 $19.58M
Total Liabilities Q3 2022 · Sep 30, 2022 $22.86M
Total Liabilities Q3 2022 · Dec 31, 2021 $32.04M
Current Assets Q3 2022 · Sep 30, 2022 $32.78M
Current Assets Q3 2022 · Dec 31, 2021 $55.67M
Total Assets Q3 2022 · Sep 30, 2022 $38.6M
Total Assets Q3 2022 · Dec 31, 2021 $62.77M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.18
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.53
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.31
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.96
Eps Basic Q3 2022 · Sep 30, 2022 −$0.18
Eps Basic Q3 2022 · Sep 30, 2022 −$0.53
Eps Basic Q3 2022 · Sep 30, 2021 −$0.31
Eps Basic Q3 2022 · Sep 30, 2021 −$0.96
Sga Expense Q3 2022 · Sep 30, 2022 $3.41M
Sga Expense Q3 2022 · Sep 30, 2022 $10.29M
Sga Expense Q3 2022 · Sep 30, 2021 $4.26M
Sga Expense Q3 2022 · Sep 30, 2021 $12.08M
Rd Expense Q3 2022 · Sep 30, 2022 $5.05M
Rd Expense Q3 2022 · Sep 30, 2022 $15.52M
Rd Expense Q3 2022 · Sep 30, 2021 $7.81M
Rd Expense Q3 2022 · Sep 30, 2021 $21.48M
Net Income Q3 2022 · Sep 30, 2022 −$5.78M
Net Income Q3 2022 · Sep 30, 2022 −$17.48M
Net Income Q3 2022 · Jun 30, 2022 −$5.04M
Net Income Q3 2022 · Mar 31, 2022 −$6.66M
Net Income Q3 2022 · Sep 30, 2021 −$10.19M
Net Income Q3 2022 · Sep 30, 2021 −$30.97M
Net Income Q3 2022 · Jun 30, 2021 −$10.5M
Net Income Q3 2022 · Mar 31, 2021 −$10.28M
Operating Income Q3 2022 · Sep 30, 2022 −$5.74M
Operating Income Q3 2022 · Sep 30, 2022 −$17.09M
Operating Income Q3 2022 · Sep 30, 2021 −$9.94M
Operating Income Q3 2022 · Sep 30, 2021 −$30.18M
Revenue Q3 2022 · Sep 30, 2022 $2.72M
Revenue Q3 2022 · Sep 30, 2022 $8.73M
Revenue Q3 2022 · Sep 30, 2021 $2.12M
Revenue Q3 2022 · Sep 30, 2021 $3.38M